Golden Pet Brands (Dr. Marty Pets, Badlands Ranch, Ultimate Pet Nutrition) has retained Morgan Stanley and Barclays for a $1B+ New York IPO before end-2026. Two US plants in Wisconsin and Nebraska, new CPG leadership from Mars and P&G. The pricing would be the first public-market test of the US premium freeze-dried/raw category.
Read more →
Chewy closed its $400M Modern Animal acquisition in Q2 FY2026 and posted net sales of $3.33B (+7.3% YoY), driven by Autoship at 84.6% of revenue, active customers at 21.7M (+3.8%), and AI assistant Kai resolving 30% of chat volume. Management raised FY2026 guidance to $13.46–$13.57B but flagged a soft US pet market with no consumer recovery.
Read more →
Hangzhou Tianyuan Pet Products (SZSE: 301335) will appear before the SZSE M&A Review Committee on September 9, 2026 seeking approval for its RMB 640 million acquisition of 89.7145% of Guangzhou Taotong Technology , an e-commerce operator serving Mars Wrigley, PepsiCo, Nestlé, and Royal Canin. Fosun Happy Purchase will exit its 43.97% stake entirely in cash.
Read more →
Vet Plus, Inc. voluntarily recalled Fi Calming (lot 26118) and Fi 8-in-1 Formula (lot 26159) dog supplements on September 3, 2026 due to potential Salmonella contamination from a supplier ingredient. FDA published the recall on September 8. Affected lots were sold direct and via Amazon and Chewy. No illnesses reported.
Read more →
Regulation (EU) 2026/1818 on dog and cat welfare and traceability entered force on August 30, 2026, with general application from August 31, 2028. It mandates microchipping, bans cosmetic mutilations and spiked collars, requires interoperable national databases, and imposes staggered compliance deadlines from 2030 (operators) to 2041 (private cat owners).
Read more →
On August 31 and September 3, 2026, Nestlé Purina opened a USD 550 million smart factory in Batavia, Ohio — its first U.S. greenfield plant since 1975 — and secured Thailand Board of Investment approval for two combined THB 64 billion pet food and treat projects in Rayong with more than 90% export orientation.
Read more →
Four strategic pet industry deals in September 2026: Pets Choice acquired Pettex Aquatic, Paramount Retail Group sold Vital Pet Group to SPL Group, Boehringer Ingelheim acquired Swiss biotech Evax for equine vaccines, and Ever After Foods acquired Belgian Fishway for cultivated protein in premium pet food.
Read more →
Lickicious, an Indian digital-first pet food brand, raised INR 19 crore (USD 2.3 million) led by Prath Ventures to build a 60,000-square-foot manufacturing facility, targeting INR 100 crore revenue and a top-three position in India's growing pet food market.
Read more →
Blue Sea Capital acquired a majority stake in CompletePet, a U.S. pet supplement contract manufacturer with facilities in Miami, Florida, and Milton, Vermont, providing outsourced formulation and manufacturing across soft chews, oils, powders, and dental products for pet wellness brands.
Read more →
On September 3, 2026, the FDA authorized Capstar (nitenpyram) and generic nitenpyram tablets for prevention of New World screwworm in dogs and cats weighing at least 2 pounds, marking the first FDA-authorized prophylactic option for the parasite in companion animals as 48 domestic cases including 3 dogs are confirmed.
Read more →
Hong Kong-founded Buddy Bites raises $4.2M Series A led by Digitalis Ventures. Plans Taiwan expansion, cat food launch, and shelf-stable fresh food R&D. $6M ARR, 68% YoY growth.
Read more →
Standard Process launches GI Soothing probiotic supplement for dogs and cats, combining Saccharomyces boulardii, postbiotics, and botanicals. Enters growing veterinary digestive health market.
Read more →
EU ECGT Directive becomes enforceable September 27, 2026. Pet brands must audit all environmental claims. Generic 'eco-friendly' and 'sustainable' claims banned without recognized ecolabels. Penalties start at 4% of EU turnover.
Read more →
Woolworths Group acquires 55% of Petspiration Group (PETstock) for A$586M, entering Australia's $10B specialty pet sector. Founders retain 45% and continue leadership.
Read more →
Hisun Pharmaceutical and Zhongyu Pet Food broke ground on September 3, 2026, on a RMB 236 million pet prescription food plant in Taizhou, China, with 12,000 tonnes annual capacity, aiming to break the foreign monopoly on premium therapeutic pet diets.
Read more →
The DOJ filed a lawsuit on August 7, 2026, against Arrow Reliance Inc. (Darwin's Natural Pet Products), seeking an injunction after FDA testing from 2017 to 2025 repeatedly found Salmonella, Listeria, and E. coli in its raw pet food, causing infections in humans and pets.
Read more →
Lianyungang, China issued a three-year pet economy action plan targeting RMB 7 billion by 2028, with 15 tasks across industrial upgrading, e-commerce, pet-friendly city construction, and differentiated county-level specialization.
Read more →
Thailand's pet industry is projected to reach THB 100 billion (USD 3.03 billion) in 2026, growing at 19.7% CAGR since 2019, with pet food accounting for 68% of the market at THB 62.4 billion and the pet population reaching 7.28 million.
Read more →